Itsuro Nagase

1.1k total citations
22 papers, 956 citations indexed

About

Itsuro Nagase is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Itsuro Nagase has authored 22 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Physiology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Itsuro Nagase's work include Adipose Tissue and Metabolism (10 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Itsuro Nagase is often cited by papers focused on Adipose Tissue and Metabolism (10 papers), Diabetes Treatment and Management (7 papers) and Metabolism, Diabetes, and Cancer (5 papers). Itsuro Nagase collaborates with scholars based in Japan, United States and Netherlands. Itsuro Nagase's co-authors include Masayuki Saito, Kenichi Kazuta, Satoshi Yoshida, Atsunori Kashiwagi, Naoki Sakane, Teruo Kawada, Kenzo Kumamoto, Toshihide Yoshida, Toshiyuki Takasu and Takeshi Yoshida and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Itsuro Nagase

22 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Itsuro Nagase Japan 13 394 300 299 252 194 22 956
D. Morgan Brazil 6 280 0.7× 341 1.1× 301 1.0× 82 0.3× 10 0.1× 8 990
Katsumi Maezono Japan 12 501 1.3× 649 2.2× 300 1.0× 259 1.0× 7 0.0× 15 1.3k
Canan Küçükgergin Türkiye 17 167 0.4× 155 0.5× 64 0.2× 64 0.3× 54 0.3× 49 704
Günay Yetik-Anacak Türkiye 13 232 0.6× 196 0.7× 68 0.2× 19 0.1× 25 0.1× 36 622
Ramazan Memişoğulları Türkiye 13 132 0.3× 116 0.4× 113 0.4× 93 0.4× 5 0.0× 29 654
Fumihiko Sakakibara Japan 18 409 1.0× 241 0.8× 243 0.8× 118 0.5× 3 0.0× 41 974
Søs Skovsø Canada 9 231 0.6× 288 1.0× 280 0.9× 94 0.4× 5 0.0× 13 790
Julio Sevillano Spain 11 286 0.7× 173 0.6× 129 0.4× 192 0.8× 3 0.0× 23 704
Olaf Brouwers Netherlands 11 187 0.5× 165 0.6× 279 0.9× 75 0.3× 7 0.0× 12 811

Countries citing papers authored by Itsuro Nagase

Since Specialization
Citations

This map shows the geographic impact of Itsuro Nagase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Itsuro Nagase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Itsuro Nagase more than expected).

Fields of papers citing papers by Itsuro Nagase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Itsuro Nagase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Itsuro Nagase. The network helps show where Itsuro Nagase may publish in the future.

Co-authorship network of co-authors of Itsuro Nagase

This figure shows the co-authorship network connecting the top 25 collaborators of Itsuro Nagase. A scholar is included among the top collaborators of Itsuro Nagase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Itsuro Nagase. Itsuro Nagase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ono, Akira, Haruyasu Murakami, Takashi Seto, et al.. (2020). Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I Study. Drugs in R&D. 21(1). 65–78. 4 indexed citations
2.
Smith, Catherine C., Mark J. Levis, Mark R. Litzow, et al.. (2016). Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.. Journal of Clinical Oncology. 34(15_suppl). 7026–7026. 5 indexed citations
3.
Kadokura, Takeshi, Atsunori Kashiwagi, Atsushi Utsuno, et al.. (2014). Pharmacokinetic and pharmacodynamic study of ipragliflozin in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Diabetes Research and Clinical Practice. 106(1). 50–56. 30 indexed citations
4.
Kashiwagi, Atsunori, Kenichi Kazuta, Satoshi Yoshida, & Itsuro Nagase. (2013). Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 5(4). 382–391. 88 indexed citations
5.
Maruyama, Tatsuya, Takayuki Suzuki, Masahiko Hayakawa, et al.. (2012). Synthesis and Evaluation of <i>N</i>-Phenyl-(2-aminothiazol-4-yl)acetamides with Phenoxypropanolamine Moiety as Selective β3-Adrenergic Receptor Agonists. Chemical and Pharmaceutical Bulletin. 60(5). 647–658. 2 indexed citations
6.
Kadokura, Takeshi, Masako Saitō, Atsushi Utsuno, et al.. (2011). Ipragliflozin (ASP1941), a selective sodium-dependent glucose cotransporter 2 inhibitor, safely stimulates urinary glucose excretion without inducing hypoglycemia in healthy Japanese subjects. Diabetology International. 2(4). 172–182. 33 indexed citations
7.
Maruyama, Tatsuya, Masahiko Hayakawa, Takayuki Suzuki, et al.. (2010). Synthesis and Evaluation of Novel Phenylethanolamine Derivatives containing Acetanilides as Potent and Selective .BETA.3-Adrenergic Receptor Agonists. Chemical and Pharmaceutical Bulletin. 58(4). 533–545. 10 indexed citations
8.
Maruyama, Tatsuya, Masahiko Hayakawa, Norio Seki, et al.. (2009). Synthesis and evaluation of novel phenoxypropanolamine derivatives containing acetanilides as potent and selective β3-adrenergic receptor agonists. Bioorganic & Medicinal Chemistry. 17(9). 3283–3294. 5 indexed citations
9.
Nakano, Ryosuke, Atsuo Tahara, Toshiyuki Takasu, et al.. (2009). Effects of the dipeptidyl peptidase-IV inhibitor ASP8497 on glucose tolerance in animal models of secondary failure. European Journal of Pharmacology. 622(1-3). 71–77. 3 indexed citations
10.
Tahara, Atsuo, Ryosuke Nakano, Itsuro Nagase, et al.. (2008). Pharmacological profile of ASP8497, a novel, selective, and competitive dipeptidyl peptidase-IV inhibitor, in vitro and in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 377(3). 209–217. 10 indexed citations
11.
Tahara, Atsuo, et al.. (2008). ASP8497 is a novel selective and competitive dipeptidyl peptidase-IV inhibitor with antihyperglycemic activity. Biochemical Pharmacology. 76(1). 98–107. 15 indexed citations
12.
Takasu, Toshiyuki, Masashi Ukai, Shuichi Sato, et al.. (2007). Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function. Journal of Pharmacology and Experimental Therapeutics. 321(2). 642–647. 261 indexed citations
13.
Nagase, Itsuro, Toshihide Yoshida, & Masayuki Saito. (2001). Up‐regulation of uncoupling proteins by β‐adrenergic stimulation in L6 myotubes. FEBS Letters. 494(3). 175–180. 39 indexed citations
14.
Nakamura, Yoshiko, Itsuro Nagase, Atsushi Asano, et al.. (2001). .BETA.3-Adrenergic Agonist Up-Regulates Uncoupling Proteins 2 and 3 in Skeletal Muscle of the Mouse.. Journal of Veterinary Medical Science. 63(3). 309–314. 30 indexed citations
15.
16.
Yoshida, Takeshi, Naoki Sakane, T. Umekawa, et al.. (1999). Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. International Journal of Obesity. 23(6). 570–575. 50 indexed citations
17.
Yoshida, Toshihide, Tsunekazu Umekawa, Kenzo Kumamoto, et al.. (1998). β3-Adrenergic agonist induces a functionally active uncoupling protein in fat and slow-twitch muscle fibers. American Journal of Physiology-Endocrinology and Metabolism. 274(3). E469–E475. 40 indexed citations
18.
Nagase, Itsuro. (1996). EXPRESSION OF UNCOUPLING PROTEIN IN SKELETAL MUSCLE AND WHITE FAT OF OBESE MICE TREATED WITH A THERMOGENIC β3-ADRENERGIC AGONIST. Jūigaku kenkyū/Japanese journal of veterinary research. 44(1). 24–24. 2 indexed citations
19.
Nagase, Itsuro, Takeshi Yoshida, Kenzo Kumamoto, et al.. (1996). Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist.. Journal of Clinical Investigation. 97(12). 2898–2904. 172 indexed citations
20.
Nagase, Itsuro, Noriko Sasaki, Katsumi Tsukazaki, et al.. (1994). Hyperplasia of brown adipose tissue after chronic stimulation of beta 3-adrenergic receptor in rats.. PubMed. 42(3-4). 137–45. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Morgan Breakdown of academic impact, for papers by Katsumi Maezono Breakdown of academic impact, for papers by Canan Küçükgergin Breakdown of academic impact, for papers by Günay Yetik-Anacak Breakdown of academic impact, for papers by Ramazan Memişoğulları Breakdown of academic impact, for papers by Fumihiko Sakakibara Breakdown of academic impact, for papers by Søs Skovsø Breakdown of academic impact, for papers by Julio Sevillano Breakdown of academic impact, for papers by Olaf Brouwers
Rankless by CCL
2026